Indraprastha Medical Corporation Performance
- Today's Low
- ₹377
- Today's High
- ₹384
- 52 Week Low
- ₹342
- 52 Week High
- ₹641
- Open Price₹379
- Previous Close₹381
- Volume59,605
- 50 DMA₹388.09
- 100 DMA₹399.24
- 200 DMA₹415.24
Indraprastha Medical Corporation Chart
Investment Returns
- Over 1 Month -1.13%
- Over 3 Month -13.4%
- Over 6 Month -7.88%
- Over 1 Year -22.03%
Smart Investing Starts Here Start SIP with Indraprastha Medical Corporation for Steady Growth!
Indraprastha Medical Corporation Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 19
- PEG Ratio
- 1.4
- Market Cap Cr
- 3,485
- P/B Ratio
- 4.7
- Average True Range
- 11.73
- EPS
- 20.03
- Dividend Yield
- 1.2
- MACD Signal
- -1.37
- RSI
- 47.53
- MFI
- 63.6
Latest Stock News Updates
Healthcare Facilities company Indraprastha Medical Corporation announced Q4FY26 & FY26 results Financial Highlights: Revenue from Operations: For Q4FY26, revenue stood at Rs 364.81 crore, representing a decrease of 1.83% QoQ from Rs 371.61 crore in Q3FY26 and an increase of 9.31% YoY from Rs 333.75 crore in Q4FY25. For FY26, revenue reached Rs 1,482.51 crore compared to Rs 1,356.36 crore in FY25, marking a growth of 9.30% YoY. Total Income: For Q4FY26, total income was Rs 372.14 crore, a marginal decrease of 1.75% QoQ from Rs 378.76 crore and an increase of 9.42% YoY from Rs 340.10 crore in Q4FY25. The annual total income for FY26 stood at Rs 1,511.26 crore, reflecting a 9.59% YoY growth from Rs 1,379.01 crore in FY25. Profit After Tax (PAT): For Q4FY26, the company reported a PAT of Rs 41.70 crore, showing an increase of 1.71% QoQ from Rs 41.00 crore in Q3FY26 and an increase of 1.68% YoY from Rs 41.01 crore in Q4FY25. The annual PAT for FY26 reached Rs 183.62 crore, representing a growth of 14.06% YoY compared to Rs 160.99 crore in FY25. Earnings Per Share (EPS): The basic and diluted EPS for FY26 was Rs 20.03, up from Rs 17.56 in FY25. Business Highlights: Dividend: The Board of Directors has recommended a final dividend of 40% i.e., Rs 4.00 per equity share (face value of Rs 10 each) for FY26. Segment Performance: The Company operates in a single segment, Healthcare. Accordingly, there are no additional disclosures to be made under Ind AS 108 on Operating Segments. Corporate Structure: As of March 31, 2026, the Company does not have any subsidiary, associate, or joint venture companies. Regulatory Compliance: The Company confirmed that it does not fall under the criteria of "Large Corporate (LC)" as specified by SEBI circulars. Labour Code Impact: The Government of India has consolidated 29 existing labour legislations into four Labour Codes. The Company has accounted for the incremental estimated liability in the statement of audited financial results for the current year. Result PDF
- Trendlyne
- 2 months ago
Indraprastha Medical has witnessed a decisive breakout above a key resistance level on the daily timeframe, followed by a healthy retracement that has been absorbed well by the market.
- Business Standard
- 8 months ago
The sharp upsurge in Indraprastha shares can be linked to the revisions announced by the Central Government Health Services (CGHS) - its biggest in 15 years.
- NDTV Profit
- 9 months ago
Indraprastha Medical Corporation Financials
Indraprastha Medical Corporation Technicals
EMA & SMA
- Bearish Moving Average 14
- Bullish Moving Average 2
- 20 Day
- ₹383.40
- 50 Day
- ₹388.10
- 100 Day
- ₹399.20
- 200 Day
- ₹415.20
Resistance and Support
- R3 389.67
- R2 386.58
- R1 383.72
- S1 377.77
- S2 374.68
- S3 371.82
Indraprastha Medical Corporation Corporate Actions - Bonus, Splits, Dividends
About Indraprastha Medical Corporation
- NSE Symbol
- INDRAMEDCO
- BSE Symbol
- 532150
- Managing Director
- Mr. Shivakumar Pattabhiraman
- ISIN
- INE681B01017
Similar Stocks to Indraprastha Medical Corporation
Popular Stocks
Indraprastha Medical Corporation FAQs
Indraprastha Medical Corporation share price is ₹380 As on 13 July, 2026 | 12:36
The Market Cap of Indraprastha Medical Corporation is ₹3484.9 Cr As on 13 July, 2026 | 12:36
The P/E ratio of Indraprastha Medical Corporation is 19 As on 13 July, 2026 | 12:36
The PB ratio of Indraprastha Medical Corporation is 4.7 As on 13 July, 2026 | 12:36
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.